Argo
-
Argo has recognized $37.7mn of prior year development (PYD) in the first nine months of 2022, which falls within the retained loss corridor of $75mn in the loss portfolio transfer (LPT) deal the specialty insurer struck with Enstar in Q2 for its US insurance back-book.
-
The specialty insurer booked an $11.9mn overall net adverse reserve development, up from $6.2mn last year, fueled by a $16.2mn charge in the US business.
-
The activist investor has been trying to join the board of the struggling firm and has been interviewed by Argo.
-
The company said the resignation was due to “professional and personal commitments”.
-
Argo Group has been sued by investors, who claim the company has engaged in inadequate underwriting and misrepresentation of facts which resulted in a 60% drop in the specialty carrier’s common stock value this year.
-
Bobman said the board of directors “demonstrated poor judgment” by approving the recruitment of Jessica Snyder as president of Argo’s US insurance division.
-
Capital Returns Master has proposed its president Ronald Bobman and David Michelson, president of DWM Consulting, as two new Argo board members.
-
A broader approach to deal structure leaves room open for a private firm to reverse into the company to go public.
-
Insurance Insider selects 10 exclusive news stories reported by our team on the frontline at Monte Carlo Rendez-Vous.
-
Westfield will take on 2021 and 2022 as part of the agreement, but it is not yet clear if 2020 will be included in a legacy deal Argo struck this year for 2018 and 2019 in the run-up to sale.
-
Goldman Sachs has reapproached potential bidders as the Bermudian moves rapidly following the recent legacy deal and divestiture.
-
The deal price represents 1.16x tangible book value.
Most Recent
-
Voss among multiple European TL resignations from Dual
30 April 2025 -
PartnerRe non-life segment swings to Q4 profit
30 April 2025 -
Daily Digest: Top news from 30 April
30 April 2025 -
Munich Re Specialty takes AIG’s Horton
30 April 2025 -
Peak Re books 84% P&C CoR for 2024
30 April 2025 -
Canopius to lead Willis follow facility Gemini
30 April 2025